Biofrontera Receives Extension to Regain Nasdaq Compliance
Market News

Biofrontera Receives Extension to Regain Nasdaq Compliance

Biofrontera (BFRI) has released an update to notify the public and investors about listing compliance status.

Biofrontera Inc. disclosed a non-compliance notice with Nasdaq’s listing requirements received on November 22, 2023, as reported in a Form 8-K. The company submitted a compliance plan on January 8, 2024, and was subsequently granted a 180-day extension by Nasdaq until May 20, 2024, to meet the listing criteria.

For further insights into BFRI stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskBiofrontera Announces Promising Phase 3 Study Results
TheFlyBiofrontera announces results in Phase 3 study of Ameluz-PDT for sBCC
TheFlyBiofrontera Inc. announces database lock of Phase 3 study of Ameluz-PDT
Go Ad-Free with Our App